A detailed history of Northern Trust Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Northern Trust Corp holds 8,835,453 shares of LLY stock, worth $7.25 Billion. This represents 1.2% of its overall portfolio holdings.

Number of Shares
8,835,453
Previous 9,132,343 3.25%
Holding current value
$7.25 Billion
Previous $5.32 Billion 29.12%
% of portfolio
1.2%
Previous 0.97%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$592.2 - $792.28 $176 Million - $235 Million
-296,890 Reduced 3.25%
8,835,453 $6.87 Billion
Q4 2023

Feb 13, 2024

SELL
$525.19 - $619.13 $539 Million - $635 Million
-1,025,932 Reduced 10.1%
9,132,343 $5.32 Billion
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $154 Million - $213 Million
355,317 Added 3.62%
10,158,275 $5.46 Billion
Q2 2023

Aug 11, 2023

SELL
$350.74 - $468.98 $241 Million - $322 Million
-687,502 Reduced 6.55%
9,802,958 $4.6 Billion
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $28.2 Million - $33.2 Million
-90,928 Reduced 0.86%
10,490,460 $3.6 Billion
Q4 2022

Feb 13, 2023

SELL
$321.55 - $374.67 $41.1 Million - $47.9 Million
-127,805 Reduced 1.19%
10,581,388 $3.87 Billion
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $52.3 Million - $59.6 Million
-176,383 Reduced 1.62%
10,709,193 $3.46 Billion
Q2 2022

Aug 12, 2022

SELL
$278.73 - $327.27 $107 Million - $125 Million
-382,159 Reduced 3.39%
10,885,576 $3.53 Billion
Q1 2022

May 13, 2022

SELL
$234.69 - $291.66 $42.2 Million - $52.5 Million
-179,919 Reduced 1.57%
11,267,735 $3.23 Billion
Q4 2021

Feb 08, 2022

SELL
$224.85 - $279.04 $8.56 Million - $10.6 Million
-38,076 Reduced 0.33%
11,447,654 $3.16 Billion
Q3 2021

Nov 15, 2021

BUY
$221.6 - $272.71 $268 Million - $329 Million
1,207,184 Added 11.74%
11,485,730 $2.65 Billion
Q2 2021

Aug 13, 2021

SELL
$180.55 - $233.54 $13.1 Million - $16.9 Million
-72,459 Reduced 0.7%
10,278,546 $2.36 Billion
Q1 2021

May 12, 2021

SELL
$164.32 - $212.72 $69 Million - $89.4 Million
-420,134 Reduced 3.9%
10,351,005 $1.93 Billion
Q4 2020

Feb 11, 2021

SELL
$130.46 - $172.63 $30.2 Million - $40 Million
-231,509 Reduced 2.1%
10,771,139 $1.82 Billion
Q3 2020

Nov 16, 2020

SELL
$146.22 - $169.13 $21.3 Million - $24.7 Million
-145,794 Reduced 1.31%
11,002,648 $1.63 Billion
Q2 2020

Aug 14, 2020

BUY
$136.42 - $164.18 $30.9 Million - $37.1 Million
226,212 Added 2.07%
11,148,442 $1.83 Billion
Q1 2020

May 14, 2020

SELL
$119.05 - $147.35 $918,827 - $1.14 Million
-7,718 Reduced 0.07%
10,922,230 $1.52 Billion
Q4 2019

Feb 14, 2020

SELL
$106.92 - $132.43 $11.8 Million - $14.7 Million
-110,635 Reduced 1.0%
10,929,948 $1.44 Billion
Q3 2019

Nov 13, 2019

SELL
$106.79 - $116.16 $1.66 Million - $1.8 Million
-15,515 Reduced 0.14%
11,040,583 $1.23 Billion
Q2 2019

Aug 13, 2019

BUY
$110.79 - $129.32 $3.59 Million - $4.19 Million
32,421 Added 0.29%
11,056,098 $1.22 Billion
Q1 2019

May 13, 2019

SELL
$111.31 - $131.02 $68.5 Million - $80.6 Million
-615,145 Reduced 5.29%
11,023,677 $1.43 Billion
Q4 2018

Feb 12, 2019

BUY
$105.9 - $118.64 $44.1 Million - $49.4 Million
416,787 Added 3.71%
11,638,822 $1.35 Billion
Q3 2018

Nov 14, 2018

SELL
$85.86 - $107.31 $710,577 - $888,097
-8,276 Reduced 0.07%
11,222,035 $1.2 Billion
Q2 2018

Sep 18, 2018

SELL
$75.7 - $86.88 $5.72 Million - $6.57 Million
-75,598 Reduced 0.67%
11,230,311 $958 Million
Q2 2018

Aug 14, 2018

BUY
$75.7 - $86.88 $258,288 - $296,434
3,412 Added 0.03%
11,305,909 $965 Million
Q1 2018

May 09, 2018

SELL
$74.21 - $87.6 $35.1 Million - $41.5 Million
-473,444 Reduced 4.02%
11,302,497 $874 Million
Q4 2017

Feb 14, 2018

SELL
$81.94 - $87.89 $21.8 Million - $23.4 Million
-265,813 Reduced 2.21%
11,775,941 $995 Million
Q3 2017

Nov 13, 2017

BUY
$77.07 - $85.54 $928 Million - $1.03 Billion
12,041,754
12,041,754 $1.03 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $779B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.